Amgen Inc $137.96

down -1.42


2/9/2014 04:00 PM  |  NASDAQ : AMGN  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get AMGN Trend Analysis - it has outperformed the S&P 500 by 4%

Partner Headlines

  1. Novartis, Regeneron Cardio Results Pump Up Wall St.

    IBD
  2. Novartis, Regeneron Hit New Highs On Cardio Drugs

    IBD
  3. Amgen edges up on trial results

    IBD
  4. Stocks Hitting 52-Week Highs

    Benzinga
  5. Biotech ETFs Hitting New Highs On Takeover News (FBT, PBE, ITMN)

    Benzinga
  6. After Reaching All-Time Highs, How Can Gilead Sciences Continue growing?

    GuruFocus
  7. HCP Boosts Of 29 Years Of Dividend Increases

    IBD
  8. The Tech Industry is Vanishing Before Our Eyes

    FoxBusiness
  9. Stocks End With Small Gains; Amgen Shrugs Off Drug Data

    IBD
  10. AMGEN

    IBD
  11. Top 4 Stocks In The Biotechnology Industry With The Highest Revenue

    Benzinga
  12. 4 Top-Rated Drugmakers Beat Q2 Earnings Estimates

    IBD
  13. Cancer 'Cocktail' Passes Test

    IBD
  14. Nasdaq Leads In Quiet Session; Priceline Nears Buy Point

    IBD
  15. Amgen Cancer Drug Kyprolis Succeeds In Trial

    IBD
  16. Morning Market Movers

    Benzinga
  17. Benzinga's Top #PreMarket Gainers

    Benzinga
  18. UPDATE: Amgen Announces Phase 3 ASPIRE Trial of Kyprolis Met Primary Endpoint, ...

    Benzinga
  19. Stocks Mixed Despite Better-Than-Expected GDP

    Benzinga
  20. Amgen Price Target Raised by Various Analysts

    Benzinga
  21. Amgen Restructuring Plan, Q2 Earnings Send Stock Up

    IBD
  22. Quarterly “Beats”: Bah, Here Are Real Growers

    YCharts
  23. Amgen To Slash Workforce

    IBD
  24. Indexes End Lower As Russia Sanctions Hit Stocks

    IBD
  25. Stock Futures Show Some Muscle; Merck, Cognex Rising

    IBD
  26. Earnings Scheduled For July 29, 2014

    Benzinga
  27. Top 5 Earnings Reports To Watch After The Close Tue.

    IBD
  28. Pfizer, Merck, Amgen Near Q2 Earnings Reports

    IBD
  29. Benzinga Weekly Preview: FOMC In Focus, As Earnings Season Progresses

    Benzinga
  30. US Stock Futures Drop Ahead Of Durable Goods Orders Data

    Benzinga
  31. Biotech Enters Reporting Season With Large Caps Central To Sector Performance

    Benzinga
  32. UPDATE: Amgen Announces Positive Phase 3 Results For AMG 416 For the Treatment ...

    Benzinga
  33. Yellen Swats Down Biotech, Social Media Stocks

    FoxBusiness
  34. Morgan Stanley Issues 2015 'Vintage Values' Stock List

    Benzinga
  35. Celgene Drug Otezla Fails Trial, But Street Sanguine

    IBD
  36. Alexion Pharma Looks To Life Beyond Its Blockbuster

    IBD
  37. Bind Therapeutics

    IBD
  38. Citi Sees Plenty Of Q2 Earnings Beats Ahead In Biotech Sector

    Benzinga
  39. Bind Therapeutics Down After Losing Amgen Partnership

    IBD
  40. Dow Hits 17,000 On Jobs Report; Walgreen Same-Store-Sales Surge 7.5%

    Benzinga
  41. Morning Market Losers

    Benzinga
  42. Top 4 Stocks In The Biotechnology Industry With The Highest EPS

    Benzinga
  43. Benzinga's M&A Chatter for Monday June 16, 2014

    Benzinga
  44. InterMune Up On Bullish View Of U.S. Esbriet Launch

    IBD
  45. UPDATE: Morgan Stanley Reiterates On Amgen On New CFO

    Benzinga
  46. Teva Acquiring Labrys Biologics For Migraine Drug

    IBD
  47. UPDATE: Morgan Stanley Reiterates On Amgen Following AMAGINE-1 Study

    Benzinga
  48. Gulf Resources (GURE) Impressive Performance, Amgen (AMGN) and AstraZeneca ...

    GuruFocus
  49. Amgen

    IBD
  50. Top 4 NASDAQ Stocks In The Biotechnology Industry With The Highest EPS

    Benzinga
Trading Center